Mehmet Oz, President-elect Donald Trump’s choice to run the Centers for Medicare & Medicaid Services, recently held investments in health care, tech, and food companies that would pose significant ...

Imkeldi is supplied as a strawberry-flavored oral solution in a 140 mL, child-resistant, tamper-evident bottle.

The approval is supported by data from the COBLT study, FDA dockets and public information, and an observational database.

CNSide can aid the diagnosis and management of leptomeningeal metastases in patients with cancer, a new study suggests.

A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.

ALA fluorescence-guided surgery improved the rate of gross total resection in a phase 3 trial of patients with glioblastoma.

Source: Getty Images Mehmet Oz, President-elect Donald Trump’s choice to run the Centers for Medicare & Medicaid Services, ...

Paltusotine can alleviate symptoms of carcinoid syndrome in patients with neuroendocrine tumors, a phase 2 study suggests.

NP-101 plus nivolumab and ipilimumab demonstrated activity in patients with metastatic EP-NECs that were refractory to chemotherapy.

The combination of chemotherapy and radioembolization appeared safe and effective in patients with well-differentiated, liver-dominant, grade 3 NETs.

rhIL‑7-hyFc was not associated with improved survival in the overall cohort but was associated with improved survival in older patients. Adding rhIL‑7-hyFc, a long-acting IL-7, to treatment with ...

The median progression-free survival was 9.9 months in patients who received TTFields upfront and 5.6 months in patients who did not. Adding tumor-treating fields (TTFields) to first-line ...